Rossiyskaya Gazeta: Breakthrough skin cancer medicine undergoes clinical testing in Russia
![](https://cdn1.tass.ru/width/333_3412a45b/tass/m2/en/uploads/i/20161228/1157380.jpg)
A source that is involved in clinical testing told the newspaper that "the new medicine is twice as efficient as conventional therapy." "The majority of patients with metastatic melanoma virtually face a death-warrant as today’s cancer therapy usually uses chemotherapy, which can only retain metastases in 10-20% of cases," company representative said. The new medicine may be widely used for treating cancer by 2018 as clinical tests have been successful so far, he added.
No comments:
Post a Comment